ArticleFrontiers in medicine2026
The role of cytokines in acute gastrointestinal injury: a prospective pilot study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cheonggukjang-DerivedMetabolites · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the association between cytokines and the severity of acute gastrointestinal injury (AGI) in critically ill patients on day 3 after intensive care unit (ICU) admission. Methods: This was a single-center, prospective observational cohort study. We collected blood samples for 5 consecutive days and measured interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor-alpha (TNF- Results: A total of 116 patients were included in the final analysis. On day 1 after ICU admission, the levels of plasma biomarkers, such as IL-6, IL-10, TNF- Conclusion: In critically ill patients with AGI, the levels of cytokines on day 1 after ICU admission were positively associated with persistent intestinal failure during the early acute phase. Cytokines may partially mediate the relationship between intestinal injury and progression to persistent intestinal failure. Controlling the inflammatory response may represent a potential therapeutic strategy for acute gastrointestinal injury. Clinical trial registration: This study was registered with the Chinese Clinical Trial Registry on 21 February 2022 (Registration ID: ChiCTR2200056858).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.